05/01/2024
4:08 PM | Adage Capital Management, L.P. (Filed by)
EyePoint Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/30/2024
7:53 PM | Adage Capital Management, L.P. (Filed by)
EyePoint Pharmaceuticals (Subject)
| Form SC 13G | |
04/22/2024
3:15 PM | Adage Capital Management, L.P. (Reporting)
Atchinson Robert (Reporting)
EyePoint Pharmaceuticals (Issuer)
Gross Phillip (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/02/2024
4:27 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
12:53 PM | EyePoint Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/07/2024
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
4:37 PM | EyePoint Pharmaceuticals (Issuer)
Ribeiro Ramiro (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
|
03/04/2024
4:40 PM | EyePoint Pharmaceuticals (Issuer)
Ribeiro Ramiro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:01 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:08 PM | EyePoint Pharmaceuticals (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
02/13/2024
4:37 PM | Duker Jay S. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:38 PM | Elston George (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:38 PM | EyePoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:39 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:40 PM | EyePoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
11:00 AM | EyePoint Pharmaceuticals (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:54 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
EyePoint Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/06/2024
9:55 AM | EyePoint Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
02/05/2024
4:15 PM | EyePoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:22 PM | EyePoint Pharmaceuticals (Subject)
Jones David Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024
3:53 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:51 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:54 PM | EyePoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:24 PM | EyePoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2024
5:26 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:50 PM | EyePoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
3:25 PM | EyePoint Pharmaceuticals (Subject)
Lurker Nancy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
3:42 PM | EyePoint Pharmaceuticals (Subject)
Lurker Nancy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
3:19 PM | EyePoint Pharmaceuticals (Subject)
Paggiarino Dario A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024
3:19 PM | EyePoint Pharmaceuticals (Subject)
Jones David Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/16/2024
5:55 PM | EyePoint Pharmaceuticals (Issuer)
Ocumension Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:01 PM | EyePoint Pharmaceuticals (Issuer)
Liu Ye (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
4:33 PM | EyePoint Pharmaceuticals (Subject)
Ocumension Therapeutics (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2024
3:53 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
8:28 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:17 PM | EyePoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:53 PM | ADAMIS ANTHONY P (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:53 PM | ANDO GORAN (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:54 PM | DICICCO WENDY F (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:54 PM | Duty Stuart (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Long-Awaited End of America Update (Ad) A 995% Gain Last Time We Shared this "Election Secret"
It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it. Click here to find out for free. |
01/09/2024
7:55 PM | EyePoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
7:56 PM | EyePoint Pharmaceuticals (Issuer)
GUYER DAVID R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:04 PM | Elston George (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:07 PM | Duker Jay S. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:09 PM | EyePoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:11 PM | EyePoint Pharmaceuticals (Issuer)
Pine Michael Craig (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
8:12 PM | EyePoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
5:37 PM | EyePoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4/A | |
01/02/2024
4:41 PM | EyePoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2023
4:14 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:52 PM | Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
4:28 PM | EW Healthcare Partners, L.P. (Filed by)
EyePoint Pharmaceuticals (Subject)
| Form SC 13D/A | |
12/07/2023
8:21 PM | EyePoint Pharmaceuticals (Issuer)
Ocumension Therapeutics (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
8:03 PM | EyePoint Pharmaceuticals (Issuer)
Liu Ye (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
5:11 AM | EyePoint Pharmaceuticals (Filer)
| Form 424B5 | |
12/06/2023
4:18 PM | EyePoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:19 PM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
4:20 PM | EyePoint Pharmaceuticals (Issuer)
Pine Michael Craig (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
3:39 PM | Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
7:54 AM | EyePoint Pharmaceuticals (Subject)
Ocumension Therapeutics (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
4:31 PM | EyePoint Pharmaceuticals (Filer)
| Form 424B5 | |
12/04/2023
3:34 PM | EyePoint Pharmaceuticals (Subject)
Lurker Nancy (Reporting)
| Form 144/A | |
12/04/2023
3:15 PM | EyePoint Pharmaceuticals (Subject)
Pine Michael Craig (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
3:16 PM | EyePoint Pharmaceuticals (Subject)
Paggiarino Dario A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
2:39 PM | EyePoint Pharmaceuticals (Subject)
Lurker Nancy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:00 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
2:47 PM | EyePoint Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/01/2023
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
11:15 PM | EyePoint Pharmaceuticals (Filer)
| Form EFFECT | |
10/20/2023
4:15 PM | EyePoint Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/20/2023
4:18 PM | EyePoint Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/17/2023
3:47 PM | Elston George (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
3:48 PM | Duty Stuart (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2023
3:49 PM | Duty Stuart (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2023
6:06 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
10:15 AM | EyePoint Pharmaceuticals (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
09/11/2023
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2023
6:10 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4/A | |
09/01/2023
3:51 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
4:46 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2023
4:22 PM | EW Healthcare Partners, L.P. (Filed by)
EyePoint Pharmaceuticals (Subject)
| Form SC 13D/A | |
08/30/2023
4:32 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4/A | |
08/28/2023
5:32 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
4:30 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:23 PM | EW Healthcare Partners-A, L.P. (Reporting)
EyePoint Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2023
3:17 PM | EW Healthcare Partners, L.P. (Reporting)
EyePoint Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/04/2023
2:09 PM | EyePoint Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2023
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Urgent dollar warning (Ad) Your 2024 Election Money Blueprint
Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today. Find out for free here. |
07/12/2023
5:51 PM | EyePoint Pharmaceuticals (Issuer)
Zaderej Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:52 PM | EyePoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
5:53 PM | Duker Jay S. (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2023
6:06 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
6:05 AM | EyePoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
4:10 PM | ADAMIS ANTHONY P (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
8:15 AM | Elston George (Reporting)
EyePoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
8:15 AM | EyePoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
8:16 AM | EyePoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
